User contributions
Jump to navigation
Jump to search
- 12:09, 4 May 2018 diff hist +170 N File:Daunorubicincytarabineliposomal.pdf Cytarabine and daunorubicin liposomal (Vyxeos) package insert (locally hosted backup). Original source: http://pp.jazzpharma.com/pi/vyxeos.en.USPI.pdf, accessed 5/4/2018. current
- 12:56, 20 April 2018 diff hist +335 m Osimertinib (Tagrisso) →History of changes in FDA indication
- 12:55, 20 April 2018 diff hist 0 File:Osimertinib.pdf PeterYang uploaded a new version of File:Osimertinib.pdf current
- 12:23, 19 April 2018 diff hist -1 m Fostamatinib (Tavalisse) formatting
- 12:06, 19 April 2018 diff hist 0 File:Pembrolizumab.pdf PeterYang uploaded a new version of File:Pembrolizumab.pdf
- 12:03, 19 April 2018 diff hist 0 File:Nivolumab.pdf PeterYang uploaded a new version of File:Nivolumab.pdf
- 12:02, 19 April 2018 diff hist +273 m Nivolumab (Opdivo) FDA approval
- 12:01, 19 April 2018 diff hist +328 Ipilimumab (Yervoy)
- 11:58, 19 April 2018 diff hist 0 File:Ipilimumab.pdf PeterYang uploaded a new version of File:Ipilimumab.pdf
- 11:55, 19 April 2018 diff hist +28 m Immune thrombocytopenia →Fostamatinib (Tavalisse) {{#subobject:ddb228|Regimen=1}}
- 11:54, 19 April 2018 diff hist +903 Immune thrombocytopenia →Relapsed or refractory: added Fostamatinib (Tavalisse)
- 11:47, 19 April 2018 diff hist +664 Fostamatinib (Tavalisse)
- 11:41, 19 April 2018 diff hist +9 m Fostamatinib (Tavalisse) →Also known as
- 11:34, 19 April 2018 diff hist +9 m Drug index →F
- 11:34, 19 April 2018 diff hist +1,557 Fostamatinib (Tavalisse) FDA approval
- 11:24, 19 April 2018 diff hist +173 N File:Fostamatinib.pdf Fostamatinib (Tavalisse) package insert (locally hosted backup). Original source: http://tavalisse.com/downloads/pdf/Full-Prescribing-Information.pdf, accessed on 4/19/2018. current
- 11:22, 19 April 2018 diff hist +38 N Fostamatinib (R788) PeterYang moved page Fostamatinib (R788) to Fostamatinib (Tavalisse): FDA approval current
- 11:22, 19 April 2018 diff hist 0 m Fostamatinib (Tavalisse) PeterYang moved page Fostamatinib (R788) to Fostamatinib (Tavalisse): FDA approval
- 05:48, 17 April 2018 diff hist +79 User:PeterYang
- 18:24, 12 April 2018 diff hist +4 Gestational trophoblastic neoplasia correction in dactinomycin frequency
- 14:35, 8 April 2018 diff hist +122 Renal cell carcinoma →Ipilimumab & Nivolumab {{#subobject:7bc416|Regimen=1}}: clarified description
- 12:39, 7 April 2018 diff hist +10 m Soft tissue sarcoma →Variant #3, 3-day course, lower dose doxorubicin and ifosfamide {{#subobject:0acb5d|Variant=1}}: formatting
- 07:42, 3 April 2018 diff hist +2,035 Immunotherapy toxicity management formatting, links, references
- 07:20, 3 April 2018 diff hist +240 N User:Ronaldgo Created page with "thumb|Ronald Go, MD Ronald Go, MD is a Associate Professor of Medicine at [http://www.mayo.edu/research/faculty/go-ronald-s-m-d/bio-20013527 Mayo Clinic]..." current
- 07:17, 3 April 2018 diff hist +28 N File:Ronaldgo.jpg Ronald Go, MD headshot photo current
- 07:10, 2 April 2018 diff hist -61 m Aymen's Test Page
- 07:10, 2 April 2018 diff hist -4,493 m User:Aymenelfiky reverted misplaced edits
- 07:09, 2 April 2018 diff hist +4,582 Aymen's Test Page moved over information from Aymen's profile page
- 22:50, 31 March 2018 diff hist +3 m Multiple myeloma →Risk stratification
- 19:22, 29 March 2018 diff hist +41 User:Wayneliang
- 05:58, 27 March 2018 diff hist +12 m Thrombocytosis →Initial evaluation
- 22:03, 22 March 2018 diff hist -193 m Malignant pleural mesothelioma removed Patient resource "TreatMesothelioma" --site no longer exists and redirects
- 11:27, 22 March 2018 diff hist +341 Billing codes (CPT) and wRVUs added advance care planning codes
- 11:19, 22 March 2018 diff hist +277 Billing codes (CPT) and wRVUs →Outpatient
- 05:16, 4 March 2018 diff hist +57 Anemia →Initial evaluation
- 02:48, 28 February 2018 diff hist +71 N User:Wayneliang Created page with "Wayne Liang, MD is the HemOnc.org Section Editor of Pediatric Oncology."
- 02:35, 28 February 2018 diff hist +568 N User:Sanjaisharma Created page with "thumb|Sanjai Sharma, MD Sanjai Sharma, MD, completed his Internal Medicine residency at University of Southern California and Hematology Oncology fel..."
- 02:33, 28 February 2018 diff hist +32 N File:Sanjaisharma.jpg Sanjai Sharma, MD headshot photo current
- 13:34, 26 February 2018 diff hist -11 m Esophageal cancer →Cisplatin & Etoposide {{#subobject:5a71ff|Regimen=1}}
- 11:31, 24 February 2018 diff hist +63 N User:Mcampo1 Created page with "Meghan (Campo) Mooradian MD is Section Editor of Immunotherapy." current
- 10:58, 24 February 2018 diff hist +100 N User:Ivyabraham Created page with "Ivy Abraham MD is Page Editor for the Gastric cancer and Periampullary adenocarcinoma pages."
- 10:57, 24 February 2018 diff hist +128 N User:Rozinachowdhery Created page with "Rozina Chowdhery MD is a Page Editor for the Pancreatic cancer and pancreatic neuroendocrine tumor pages."
- 10:56, 24 February 2018 diff hist +88 N User:Nainasingh Created page with "Naina Singh MD is a Page Editor for the Esophageal cancer and Anal cancer pages."
- 10:49, 24 February 2018 diff hist +184 User:Neetavenepalli added page editors
- 10:00, 24 February 2018 diff hist +863 N User:Jvarghese Created page with "thumb|Jeena Varghese, MD Dr. Varghese graduated from Adichunchanagiri Institute of Medical Sciences, Bellur, India. She then completed a residency i..."
- 09:56, 24 February 2018 diff hist +33 N File:Jeenavarghese.jpg Jeena Varghese, MD headshot photo current
- 09:07, 24 February 2018 diff hist +78 External links →Guidelines & drug information
- 06:23, 24 February 2018 diff hist +184 Deep veins and superficial veins in the arms and legs
- 13:55, 21 February 2018 diff hist +234 Breast cancer →FAC {{#subobject:1e6621|Regimen=1}}
- 01:49, 16 February 2018 diff hist +18 m Anemia →Less common